Technology News and Research

RSS

Horizon Discovery secures exclusive rights to human isogenic cell models

With the goal of developing new, more effective and personalized cancer treatments, Horizon Discovery, based in Cambridge, England, has secured from Case Western Reserve University exclusive rights to a panel of new human isogenic cell models developed by the laboratory of Zhenghe John Wang, assistant professor of genetics at the university's School of Medicine.

10 Dec 2010

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Scientists from Pacific Biosciences of California, Inc. and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the first whole genome sequence analysis and most detailed genetic profile to date of the Haitian Vibrio cholerae outbreak strain.

10 Dec 2010

TeleHealth Services announces extended partnership with Central Baptist Hospital

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extended partnership with Central Baptist Hospital. The 383-bed hospital, an early adopter to on-demand education, implemented TIGR as their interactive patient education and entertainment solution as a part of their "meaningful use" project, and the further utilization of advanced technologies to increase the quality of healthcare at the facility.

10 Dec 2010

Biovex announces OncoVEXGM-CSF Phase 3 study for head and neck cancer

BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a Phase 3 pivotal study with OncoVEXGM-CSF for the first line treatment of patients with locally advanced squamous cell carcinoma of the head & neck has commenced.

10 Dec 2010

Tobacco-cessation expert receives 2011 ASPO Joseph W. Cullen Memorial Award tobacco research

Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., Ph.D., at The University of Texas MD Anderson Cancer Center is the recipient of the 2011 American Society of Preventive Oncology (ASPO) Joseph W. Cullen Memorial Award for Excellence in Tobacco Research.

10 Dec 2010

Scientists to develop ultra-rapid sexually transmitted infection detection system for clinics

Scientists from the University of Southampton have secured funding to develop an ultra-rapid sexually transmitted infection (STI) detection system for clinics that can detect STIs in under 15 minutes.

9 Dec 2010

Research looks at early exposure to mobile phone risk

There has been plenty of speculation that mobile phones are not good for pregnant mums but a new study sheds light on the actual connection. It finds that pregnant women who regularly use mobile phones may be more likely to have children with behavioral problems, particularly if their children start using mobile phones in their first seven years. American researchers said that the risk of behavioral problems rose by 30% if such exposure was present. Those exposed before birth and in early childhood were at 50% higher risk than those who were not exposed they said.

9 Dec 2010

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.

9 Dec 2010

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

Hamilton Thorne Ltd., a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto™ laser system. The Stiletto™ laser system has broad applications for research with a variety of cells, allowing the Company to enter new and exciting research markets, including developmental and advanced cell biology.

9 Dec 2010

BDSI initiates dosing in BEMA Buprenorphine Phase 3 clinical program for chronic pain

BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.

9 Dec 2010

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.

9 Dec 2010

Ellipse's PRECICE Limb Lengthening device receives CE-Mark approval

Ellipse Technologies, Inc. announced today that it has received CE-Mark approval of the Company's PRECICETM Limb Lengthening device. Limb Lengthening procedures are used to treat a number of medical conditions, including shortened legs due to congenital abnormalities, major fractures of one of the legs and shortened leg bones due to other medical diseases, such as cancer.

9 Dec 2010

Palomar announces global availability of MaxG Optimized Pulsed Light

Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for aesthetic treatments, is pleased to announce that the MaxG™ Optimized Pulsed Light™ (OPL) handpiece is now available worldwide for use on the company's StarLux® 500 and Artisan™ laser and pulsed light aesthetic systems.

9 Dec 2010

Medical Alarm Concepts acquires controlling rights to U.S. patents RE 41845, RE 41392

Medical Alarm Concepts Holdings, Inc., manufacturer of the MediPendant™, the first fully-monitored medical alarm system that allows you to speak and listen directly through the pendant, announced today it has acquired the controlling rights to U.S. patent numbers RE 41845 and RE 41392.

9 Dec 2010

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of Mammostrat, a patented, novel test designed to help quantify the likelihood of recurrence of breast cancer following surgery and initial treatment.

9 Dec 2010

Central Logic rebrands event series to Patient Flow Summit

Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.

9 Dec 2010

Firefly enzyme offers new medical imaging agent for blood clot detection

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.

9 Dec 2010

Nitric oxide attacks key groups of proteins critical to cell survival

Nitric oxide is a toxic pollutant, but the human body also creates it and uses it to attack invading microbes and parasites. A new study by researchers at UC Davis, the Massachusetts Institute of Technology and the Japan Synchrotron Radiation Research Institute (JASRI) shows how nitric oxide, attacks an important group of proteins critical to cell survival.

9 Dec 2010

Oral contraceptives account for less than 1% of estrogen in drinking water

Contrary to popular belief, birth control pills account for less than 1 percent of the estrogens found in the nation's drinking water supplies, scientists have concluded in an analysis of studies published on the topic.

9 Dec 2010

Excreted antibiotics become potential sources of antibiotic resistant genes

When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.

9 Dec 2010

Technology News and Research

Horizon Discovery secures exclusive rights to human isogenic cell models

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

TeleHealth Services announces extended partnership with Central Baptist Hospital

Biovex announces OncoVEXGM-CSF Phase 3 study for head and neck cancer

Tobacco-cessation expert receives 2011 ASPO Joseph W. Cullen Memorial Award tobacco research

Scientists to develop ultra-rapid sexually transmitted infection detection system for clinics

Research looks at early exposure to mobile phone risk

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

BDSI initiates dosing in BEMA Buprenorphine Phase 3 clinical program for chronic pain

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Ellipse's PRECICE Limb Lengthening device receives CE-Mark approval

Palomar announces global availability of MaxG Optimized Pulsed Light

Medical Alarm Concepts acquires controlling rights to U.S. patents RE 41845, RE 41392

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Central Logic rebrands event series to Patient Flow Summit

Firefly enzyme offers new medical imaging agent for blood clot detection

Nitric oxide attacks key groups of proteins critical to cell survival

Oral contraceptives account for less than 1% of estrogen in drinking water

Excreted antibiotics become potential sources of antibiotic resistant genes

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News